Skip to main content
. 2020 Nov 12;57(6):429–434. doi: 10.1177/0004563220963847

Table 3.

Diagnosis sensitivity and specificity within different kits.

Kits Positive in case Positive in control Sensitivity (95%CI) Specificity (95%CI)
A_IgM 41 (9) 8 (122) 82.00% (69.20%,90.23%) 93.85% (88.33%,96.85%)
A_IgG 43 (7) 4 (126) 86.00% (73.81%,93.05%) 96.92% (92.36%,98.80%)
B_IgM 13 (37) 8 (122) 26.00% (15.87%,39.55%) 93.85% (88.33%,96.85%)
B_IgG 43 (7) 28 (102) 86.00% (73.81%,93.05%) 78.46% (70.63%,84.66%)
C_IgM 31 (19) 3 (127) 62.00% (48.15%,74.14%) 97.69% (93.44%,99.21%)
C_IgG 44 (6) 3 (127) 88.00% (76.20%,94.38%) 97.69% (93.44%,99.21%)
D_Ab 46 (4) 1 (129) 92.00% (81.16%,96.85%) 99.23% (95.77%,99.86%)